India Iron Deficiency Anemia Therapy Market

India Iron Deficiency Anemia Therapy Market Overview:

The India iron deficiency anemia therapy market size reached USD 0.17 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 0.24 Billion by 2033, exhibiting a growth rate (CAGR) of 3.90% during 2025-2033. The increasing anemia prevalence, especially among women and children, rising health awareness, government initiatives addressing nutritional deficiencies, the introduction of advanced treatment options, and improved healthcare infrastructures and accessibility are among the primary factors driving the market growth.

India Iron Deficiency Anemia Therapy Market Trends:

Fortification and Bioavailability-Enhancing Innovations

One of the key trends propelling the growth of the India iron deficiency anemia therapy market is the rising demand for iron-fortified foods and advanced bioavailability-enhancing formulations. Traditional oral iron supplements are often associated with gastrointestinal side effects, which can lead to poor patient adherence. To address this, manufacturers are increasingly developing innovative solutions such as microencapsulated iron, liposomal iron, and nano iron formulations that offer improved absorption and are gentler on the digestive system. Supporting this shift, the Food Fortification Resource Centre (FFRC) under the FSSAI has mandated the fortification of staple foods like rice, wheat flour, and edible oil through public distribution channels. This large-scale initiative has played a pivotal role in improving iron intake among economically disadvantaged populations. According to FFRC data, over 110 million people benefited from fortified rice distributed via India’s public distribution system in 2023. Furthermore, the National Family Health Survey (NFHS-5) revealed that more than 57% of Indian women aged 15–49 were anemic in 2023, underlining the urgent need for more effective and accessible therapies.

Government-Driven Anemia Eradication Programs

The Anemia Mukt Bharat (AMB) initiative stands as one of India’s most extensive public health efforts, targeting the reduction of iron deficiency anemia across all demographics, with a strong emphasis on adolescent girls, pregnant women, and children. Launched under the POSHAN Abhiyaan, AMB employs a multi-pronged approach that includes weekly iron-folic acid supplementation (WIFS), standardized testing and treatment protocols, and comprehensive behavior change communication campaigns. The government’s focus on last-mile delivery through frontline health workers such as ASHA and Anganwadi staff has significantly improved outreach in rural and underserved areas, fueling the demand for oral iron supplements, intravenous therapies like ferric carboxymaltose, and nutritional interventions. In 2024, over 230 million doses of iron-folic acid tablets were distributed under the AMB program, marking an 18% increase from 2023. Additionally, the government has set a target to bring down anemia prevalence among women of reproductive age from over 57% in 2023 to below 32% by 2025. To support this, the AMB budget allocation rose by 15% year-on-year, from INR 950 crore in 2023 to INR 1,092 crore in 2024.

India Iron Deficiency Anemia Therapy Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the region/country level for 2025-2033. Our report has categorized the market based on therapy, age group, and end use.

Therapy Insights:

• Oral Iron Therapy
• Parenteral Iron Therapy
• Red Blood Cell Transfusion
• Others

The report has provided a detailed breakup and analysis of the market based on the therapy. This includes oral iron therapy, parenteral iron therapy, red blood cell transfusion, and others.

Age Group Insights:

• Adults
• Pediatric
• Geriatric

A detailed breakup and analysis of the market based on the age group have also been provided in the report. This includes adults, pediatric, and geriatric.

End Use Insights:

• Clinics
• Hospitals
• Home Healthcare

The report has provided a detailed breakup and analysis of the market based on the end use. This includes clinics, hospitals, and home healthcare.

Regional Insights:

• North India
• South India
• East India
• West India

The report has also provided a comprehensive analysis of all the major regional markets, which include North India, South India, East India, and West India.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

India Iron Deficiency Anemia Therapy Market News:

• December 2024: Researchers at Cornell University announced that they would transfer their innovative technology, AnemiaPhone, to the Indian Council of Medical Research (ICMR). This device enables real-time screening and diagnosis of iron deficiency at the point of care. The integration of AnemiaPhone into national health programs, particularly those focusing on women, maternal, and child health, is expected to bolster India’s efforts against iron deficiency.
• March 2024: Cadila Pharmaceuticals announced the launch of Redshot Injection, an intravenous iron preparation developed for both adult and pediatric patients who cannot tolerate oral iron supplements. This novel therapy is tailored for rapid correction of hemoglobin levels and effective replenishment of iron stores, with a formulation designed for superior tolerability and minimal risk of anaphylaxis.
• February 2024: Emcure Pharmaceuticals launched the 'Unmask Anemia' initiative, a public health campaign focused on raising awareness about iron deficiency anemia among women. The initiative encouraged self-assessment and proactive screening to facilitate early intervention and improve long-term health outcomes.

India Iron Deficiency Anemia Therapy Market Report Coverage:

Key Questions Answered in This Report:

• How has the India iron deficiency anemia therapy market performed so far and how will it perform in the coming years?
• What is the breakup of the India iron deficiency anemia therapy market on the basis of therapy?
• What is the breakup of the India iron deficiency anemia therapy market on the basis of age group?
• What is the breakup of the India iron deficiency anemia therapy market on the basis of end use?
• What are the various stages in the value chain of the India iron deficiency anemia therapy market? 
• What are the key driving factors and challenges in the India iron deficiency anemia therapy market?
• What is the structure of the India iron deficiency anemia therapy market and who are the key players?
• What is the degree of competition in the India iron deficiency anemia therapy market? 

Key Benefits for Stakeholders:

• IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the India iron deficiency anemia therapy market from 2019-2033.
• The research report provides the latest information on the market drivers, challenges, and opportunities in the India iron deficiency anemia therapy market.
• Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the India iron deficiency anemia therapy industry and its attractiveness.
• Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.